SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

US STOCKS-S&P 500, Nasdaq post biggest weekly gains since early November

· 02/05/2021 16:57
US STOCKS-S&P 500, Nasdaq post biggest weekly gains since early November

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

J&J files COVID-19 vaccine application with the FDA

Nonfarm payrolls increase by 49,000 in January

Indexes: Dow up 0.3%, S&P 500 up 0.4%, Nasdaq up 0.6%

Updates close with volume, Russell 2000 index gains for week

By Caroline Valetkevitch

- U.S. stocks extended their recent rally on Friday and the S&P 500 and Nasdaq indexes scored their biggest weekly percentage gains since the U.S. elections in early November, boosted by optimism over earnings, stimulus talks and progress on vaccine rollouts.

Both the Dow Jones industrial average and S&P 500 rose for a fifth straight session in their longest streak of gains since August, while the S&P 500 and Nasdaq posted record closing highs for a second day in a row.

A smaller-than-expected rebound in the U.S. labor market last month highlighted the need for more government aid to shore up the economy. The Labor Department on Friday reported a 49,000 increase in nonfarm payrolls last month, but job losses in manufacturing and construction. nL1N2KA34D

U.S. President Joe Biden and his Democratic allies in Congress moved ahead with their $1.9 trillion COVID-19 relief package as lawmakers approved a budget plan that will allow them to muscle Biden's plan through in the coming weeks without Republican support. nL1N2KB0UF

"The upcoming package of stimulus is going to be big," said Alan Lancz, president of Alan B. Lancz & Associates Inc, an investment advisory firm based in Toledo.

"You have a situation where there's a lot of cash on sidelines and bonds have really underperformed, so that's helped some sectors that have really done poorly."

Upbeat earnings this week have also supported investor optimism. So far, stronger-than-expected corporate results in the fourth quarter have driven up analysts' expectations, and S&P 500 companies are on track to post earnings growth for the period instead of a decline as initially expected.

The Dow Jones Industrial Average .DJI rose 92.38 points, or 0.3%, to 31,148.24, the S&P 500 .SPX gained 15.09 points, or 0.39%, at 3,886.83 and the Nasdaq Composite .IXIC added 78.55 points, or 0.57%, at 13,856.30.

For the week, the S&P 500 gained 4.65%, the Nasdaq added 6.01% and the Dow increased 3.89%. The small-cap Russell 2000 index .RUT rose 7.7% for the week, its biggest weekly percentage gain since the week ended June 5.

The Cboe Volatility index .VIX fell and had its biggest weekly point drop since the week ended Nov. 6.

The S&P 500 technology index .SPLRCT ended down 0.2% after hitting a record high earlier in the session.

Johnson & Johnson JNJ.N rose 1.5% after the drugmaker said it had asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use. nL1N2KA3CR

Shares of GameStop Corp GME.N, caught in the recent social media-hyped trading frenzy, rose 19.2% on Friday, after online broker Robinhood lifted all the buying curbs imposed at the height of the battle between amateur investors and Wall Street hedge funds. nL4N2KB3F0

Clover Health Investments Corp CLOV.O shares ended up 5.7%. It said it would cooperate with a request from the U.S. Securities and Exchange Commission. U.S. regulators are following up on a report about Clover by short-selling specialist Hindenburg Research. nL4N2KB36L

Advancing issues outnumbered declining ones on the NYSE by a 2.33-to-1 ratio; on Nasdaq, a 1.94-to-1 ratio favored advancers.

The S&P 500 posted 34 new 52-week highs and no new lows; the Nasdaq Composite recorded 286 new highs and four new lows.

Volume on U.S. exchanges was 13.65 billion shares, compared with the 15.5 billion average for the full session over the last 20 trading days.


(Additional reporting by Devik Jain and Medha Singh in Bengaluru; Editing by Maju Samuel and Richard Chang)

((caroline.valetkevitch@thomsonreuters.com; +1 646 223 6393; Reuters Messaging: caroline.valetkevitch.thomsonreuters.com@reuters.net))